New York City-based Mount Sinai Health System has signed an agreement to incorporate a clinical decision-support platform from OpenEvidence into its Epic EHR.
The collaboration marks the AI company’s first enterprise deal with a health system. All clinicians at the seven-hospital academic network — including physicians, nurses and pharmacists — will be able to ask medical questions using natural language and receive answers backed by clinical guidelines and peer-reviewed literature.
“We are committed to advancing AI that is not only innovative but clinically meaningful, trusted, and seamlessly integrated into care delivery,” said Girish Nadkarni, MD, chief AI officer of Mount Sinai Health System, in a March 31 news release. “By embedding OpenEvidence directly into the clinical workflow, we are equipping every member of the care team with real-time access to rigorously sourced, evidence-based insights.”
OpenEvidence, which is valued at $12 billion, said it is the most commonly used medical AI platform among U.S. physicians.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.